Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Faulty digestion within intestinal epithelial cells promotes inflammation


A study by the Cluster of Excellence "Inflammation at Interfaces" finds a new approach for personalised treatment of chronic inflammatory bowel disease

20 percent of all patients with Crohn's disease, a clinical subtype of inflammatory bowel disease, have a mutation in the gene ATG16L1. This gene is involved in a cellular process called autophagy, which functions as a recycling mechanisms of aged organelles and macromolecules within cells.

Organoids, here with 400x magnification under a microscope, function partially like real bowels. The mini-bowel for research is made from stem cells in the laboratory.

Photo: Konrad Aden/IKMB

The delineation of the molecular consequences of Atg16l1 mutations on host immune system has been investigated in the Cluster of Excellence "Inflammation at Interfaces" for a long time.

Now, a team led by Cluster Board Member Professor Philip Rosenstiel and Dr Konrad Aden from the Institute of Clinical Molecular Biology (IKMB) at Kiel University and the Department of Internal Medicine I, UKSH Kiel have made a discovery with on a novel function of Atg16l1, which sheds a new light on the pathogenesis of IBD and might help to refine future treatment of IBD patients.

Starting point for the study, which has been published in the Journal of Experimental Medicine, is a new therapeutic approach for people with chronic inflammatory bowel diseases. The biological compound Interleukin 22 is an immune cell derived cytokine and has been well known for its regenerative effect on the intestinal mucosa. Now, the therapeutic potential of this cytokine is currently tested in clinical studies in IBD patients .

"Interleukin 22 is one of the key barrier protective cytokines which promotes regeneration of the intestinal mucosa. There was evidence that the intestinal mucosa is protected from certain stress reactions by IL-22. The principle is in the first stages of clinical testing," said Cluster spokesperson Professor Stefan Schreiber, Director of the Department of Internal Medicine I at the UKSH Kiel.

The risk gene for Crohn's disease, ATG16L1 is involved in this particular type of cell stress. The loss of function of the gene leads to reduced degradation of aged proteins, and thus to increased inflammation. " In light of this background we wanted to know whether proper Atg16l1 function is essential for mediating regenerative IL-22 responses in the intestinal epithelium ?" said Schreiber.

The authors investigated this central question mice carrying a knock out of the Atg16l1 gene specifically in intestinal epithelial cells. According to the lead author Dr Konrad Aden, they came to a very surprising result: "Essentially, Interleukin 22 stimulates cell growth and promotes regeneration of the intestinal mucosa. However, intestinal epithelial cells that carry a deletion of ATG16L1 in the intestinal epithelium, behave in the exact opposite way. In this case, Interleukin 22 causes a stress response in the cells, and a paradoxical cell death."

Thus, in the presence of the gene mutation, the desired protective function of Interleukin 22 is transformed into a pro-inflammatory effect. Although the study did not explicitly examine whether the known Atg16l1 variants also lead to paradoxical interleukin 22 effects in humans, it is tempting to speculate that there is relevance also for patients.

"This finding can help us to understand the complex changes in the intestinal barrier organ, which occur in chronic intestinal inflammation. In addition to pure regeneration, IL-22 is also involved in cellular programmes, which control the body's own antibiotics, and thus the intestinal flora – a delicate interaction that is disturbed in IBD. We now need to carefully examine this in humans, since it may enable a new approach for more targeted treatment," said Professor Philip Rosenstiel.

Many of the tests were performed on so-called intestinal organoids. These mini-guts are three-dimensional structures created from intestinal stem cells, embedded in a solid matrix and supplemented with special growth factors. They can be obtained from intestinal biopsies in mice and humans, and kept for a long time in the laboratory.

“These organoids are much closer to the physiology of the respective disease than a cell culture. In addition, they are something very individual. We expect that this in vitro technology will also be used in future to test the individual effectiveness of treatments in advance, and thereby avoid unnecessary treatments for patients," Aden said.

Original publication

Konrad Aden et al. ATG16L1 orchestrates interleukin-22 signaling in the intestinal epithelium via 2 cGAS/STING. Journal of Experimental Medicine. Published September 25, 2018.

Dr Konrad Aden
The Department of Internal Medicine I, UKSH Kiel
Institute of Clinical Molecular Biology, Kiel University
Tel.: 0431/500- 15167

Prof. Dr Philip Rosenstiel
Institute of Clinical Molecular Biology, Kiel University
Tel.: +49 (0)431 500 15111

Photos are available to download:
Konrad Aden

Konrad Aden, Cluster of Excellence "Inflammation at Interfaces", specialist in internal medicine at the Department of Internal Medicine I at UKSH Kiel, and research associate at the Institute of Clinical Molecular Biology (IKMB), Faculty of Medicine at Kiel University. Photo: private
Philip Rosenstiel

Philip Rosenstiel, Cluster of Excellence "Inflammation at Interfaces", Professor of Molecular Medicine at Kiel University and Director of the Institute of Clinical Molecular Biology (IKMB), Faculty of Medicine at Kiel University and the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel. Photo: Tebke Böschen / Cluster of Excellence "Inflammation at Interfaces"

Organoids, here with 400x magnification under a microscope, function partially like real bowels. The mini-bowel for research is made from stem cells in the laboratory, which were previously removed from the bowel tissue of humans or lab animals by means of colonoscopy. Photo: Konrad Aden/IKMB

Press contact:
Kerstin Nees
Tel.: (040) 8320998, E-mail:

The Cluster of Excellence "Inflammation at Interfaces" has been funded since 2007 by the Excellence Initiative of the German Government and the federal states with a total budget of 68 million Euros. It is currently in its second phase of funding. Around 300 cluster members are spread across the four locations: Kiel (Kiel University, University Medical Center Schleswig-Holstein (UKSH), Muthesius University of Fine Arts and Design (MHK)), Lübeck (University of Lübeck, UKSH), Plön (Max Planck Institute for Evolutionary Biology) and Borstel (Research Center Borstel (FZB) – Center for Medicine and Biosciences) and are researching an innovative, systematic approach to the phenomenon of inflammation, which can affect all barrier organs such as the intestines, lungs and skin.

Cluster of Excellence "Inflammation at Interfaces"
Scientific Office, Head: Dr habil. Susanne Holstein
Postal address: Christian-Albrechts-Platz 4, 24118 Kiel, Germany
Contact: Sonja Petermann
Tel.: +49 (0)431 880-4850, Fax: +49 (0)431 880-4894
Twitter: I@I @medinflame

Wissenschaftliche Ansprechpartner:

Dr Konrad Aden
The Department of Internal Medicine I, UKSH Kiel
Institute of Clinical Molecular Biology, Kiel University
Tel.: 0431/500- 15167

Prof. Dr Philip Rosenstiel
Institute of Clinical Molecular Biology, Kiel University
Tel.: +49 (0)431 500 15111

Kerstin Nees | idw - Informationsdienst Wissenschaft

More articles from Health and Medicine:

nachricht Magnesium deprivation stops pathogen growth
22.11.2019 | Universität Basel

nachricht Protection for pacemakers
22.11.2019 | ETH Zurich

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Machine learning microscope adapts lighting to improve diagnosis

Prototype microscope teaches itself the best illumination settings for diagnosing malaria

Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal...

Im Focus: Small particles, big effects: How graphene nanoparticles improve the resolution of microscopes

Conventional light microscopes cannot distinguish structures when they are separated by a distance smaller than, roughly, the wavelength of light. Superresolution microscopy, developed since the 1980s, lifts this limitation, using fluorescent moieties. Scientists at the Max Planck Institute for Polymer Research have now discovered that graphene nano-molecules can be used to improve this microscopy technique. These graphene nano-molecules offer a number of substantial advantages over the materials previously used, making superresolution microscopy even more versatile.

Microscopy is an important investigation method, in physics, biology, medicine, and many other sciences. However, it has one disadvantage: its resolution is...

Im Focus: Atoms don't like jumping rope

Nanooptical traps are a promising building block for quantum technologies. Austrian and German scientists have now removed an important obstacle to their practical use. They were able to show that a special form of mechanical vibration heats trapped particles in a very short time and knocks them out of the trap.

By controlling individual atoms, quantum properties can be investigated and made usable for technological applications. For about ten years, physicists have...

Im Focus: Images from NJIT's big bear solar observatory peel away layers of a stellar mystery

An international team of scientists, including three researchers from New Jersey Institute of Technology (NJIT), has shed new light on one of the central mysteries of solar physics: how energy from the Sun is transferred to the star's upper atmosphere, heating it to 1 million degrees Fahrenheit and higher in some regions, temperatures that are vastly hotter than the Sun's surface.

With new images from NJIT's Big Bear Solar Observatory (BBSO), the researchers have revealed in groundbreaking, granular detail what appears to be a likely...

Im Focus: New opportunities in additive manufacturing presented

Fraunhofer IFAM Dresden demonstrates manufacturing of copper components

The Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Dresden has succeeded in using Selective Electron Beam Melting (SEBM) to...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

First International Conference on Agrophotovoltaics in August 2020

15.11.2019 | Event News

Laser Symposium on Electromobility in Aachen: trends for the mobility revolution

15.11.2019 | Event News

High entropy alloys for hot turbines and tireless metal-forming presses

05.11.2019 | Event News

Latest News

New antenna tech to equip ceramic coatings with heat radiation control

22.11.2019 | Materials Sciences

Pollinator friendliness can extend beyond early spring

22.11.2019 | Life Sciences

Wound healing in mucous tissues could ward off AIDS

22.11.2019 | Life Sciences

Science & Research
Overview of more VideoLinks >>>